2013
DOI: 10.2174/092986613805290435
|View full text |Cite
|
Sign up to set email alerts
|

Anticancer Peptides and Proteins: A Panoramic View

Abstract: Despite progress in understanding carcinogenesis, cancer is still a major cause of morbidity and mortality worldwide. Treatment is complicated by the resistance to chemotherapeutics acquired by tumors, ability to repair damaged DNA, alteration of the interaction between drug and its target, and defects in the machinery that leads to apoptosis. The development of novel therapies based on biologically active peptides, especially antimicrobial peptides (AMPs), and proteins has emerged as a new strategy to defeat … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
17
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 140 publications
0
17
0
1
Order By: Relevance
“…Breast cancer cells that lack ER, PR and show low HER2 levels are often referred to as triple negative breast cancer (TNBC) 3 . In addition to lacking the three receptors, most TNBC cells evade apoptosis and avoid DNA repair mechanisms 4 . Patients diagnosed with TNBC tend to have increased recurrence and mortality rate within 5 years of cancer detection and are thus considered to have poorer prognosis 5 6 .…”
mentioning
confidence: 99%
“…Breast cancer cells that lack ER, PR and show low HER2 levels are often referred to as triple negative breast cancer (TNBC) 3 . In addition to lacking the three receptors, most TNBC cells evade apoptosis and avoid DNA repair mechanisms 4 . Patients diagnosed with TNBC tend to have increased recurrence and mortality rate within 5 years of cancer detection and are thus considered to have poorer prognosis 5 6 .…”
mentioning
confidence: 99%
“…An important challenge of the disease treatment is the resistance of some types of cancers to chemotherapy drugs. The development of new therapies based on active biological materials, in particular peptides and proteins, is an attractive research field in cancer therapy [9].…”
Section: Introductionmentioning
confidence: 99%
“…Various studies show that attention is being given to naturally derived products for the development of novel and effective chemotherapeutic drugs. 4 , 5 The therapeutic importance of biological products in the mitigation of different chronic human diseases, including cancer, has been well documented. 5 , 6 …”
Section: Introductionmentioning
confidence: 99%